Hemay181

DRUG2 trials

Sponsors

Ganzhou Hemay Pharmaceutical Co., Ltd

Conditions

Advanced Solid TumorsSolid Tumor

Phase 1

A Phase I Study of Hemay181 in Patients With Advanced Solid Tumors

RecruitingNCT05749432

Ganzhou Hemay Pharmaceutical Co., LtdSolid Tumor

Start: 2023-03-20End: 2026-07-31Target: 51Updated: 2025-04-18

A Clinical Study Evaluating the Preliminary Anti-tumor Efficacy and Safety of Hemay181

RecruitingNCT07446816

Ganzhou Hemay Pharmaceutical Co., LtdAdvanced Solid Tumors

Start: 2025-12-03End: 2027-08-01Target: 24Updated: 2026-03-03

Related Papers

A phase Ib clinical study to evaluate the safety, tolerability, pharmacokinetic profile and preliminary anti-tumor efficacy of Hemay181 in patients with advanced solid tumors.

Journal of Clinical Oncology2025-05-28